Original Query: ALL
Previous Study | Return to List | Next Study

A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01781572
Recruitment Status : Completed
First Posted : February 1, 2013
Last Update Posted : February 23, 2018
Information provided by (Responsible Party):
Array BioPharma

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 15, 2018
  Study Completion Date : February 20, 2018